scorecardresearch
Monday, August 11, 2025
HomeHealth

Health

AI’s most important architects can be neurodivergent people. Here is why

Neurodivergent voices are often excluded from policy discussions because their needs are seen as too complex or niche. But when they share lived experiences, they make these needs visible to policy-makers.

Go easy on Vitamin B6 supplements. Too much can be toxic

A side effect the medical community is worried about is peripheral neuropathy – where there is damage to the nerves outside the brain and spinal cord.

Obesity care in India is evolving—no longer just diets & surgery, it’s all about multi-specialty approach

As obesity management draws awareness and weight-loss injections are launched in India, hospitals are offering customised multidisciplinary treatments, at a cost.

Delhi HC orders examination into weight loss drug combinations, asks DCGI to seek expert consultation

The proceedings follow a PIL seeking a ban on sale of weight loss drugs that are still undergoing clinical trials internationally. The court asked DCGI to submit report within 3 months.

Shefali Jariwala’s death spotlights world of anti-ageing treatments built on big claims, little science

Anti-ageing treatments include broad spectrum of substances—from antioxidant supplements & growth hormone boosters, to testosterone therapy, among other things.

Punjab MBBS students call off strike after govt agrees to address stipends & fee demands

The development was announced by Forum of Resident Doctors, Punjab. Over 2,000 students of govt medical colleges in Amritsar, Faridkot & Patiala had been protesting since 7 May.

Why loneliness is a problem, even if it’s not an epidemic

The idea that loneliness is an ‘epidemic’ is misleading and it draws us away from sustainable solutions, rather than toward them.

Govt considers low-dose emicizumab for haemophilia, trial finds it more effective than existing treatment

‘Miracle drug’ can cost Rs 13 lakh for haemophilia A patient annually, but reduced dose found efficacious & cost-effective in small trial. Larger trial is under way.

In battle for Indian anti-obesity market, Eli Lilly’s pre-filled pen on one side, Novo Nordisk’s on other

India's anti-obesity drug market is currently valued at Rs 3,000-3,500 crore & is projected to grow nearly eightfold by 2030, according to market estimates.

Lancet report highlights gaps in immunisation—no routine vaccine for 14.4 lakh Indian kids in 2023

India after Nigeria recorded highest number of zero-dose children in 2023. The lack of immunisation against deadly diseases puts children at risk of life-threatening diseases.

On Camera

How mining, manufacturing & power sectors weighed on India’s industrial output since January 2024

India’s industrial output growth saw a 10-month low in June, with Index of Industrial Production (IIP) growing by mere 1.5% as against 1.9% in May 2025.

‘Next war may come sooner than expected, will require whole-of-nation approach’—Army chief

Gen Dwivedi framed Op Sindoor not just as retaliation to Pahalgam, but as demonstration of India’s capability to fight multi-domain conflicts with integration between services & agencies.

Modi’s ready to risk it all for farmers. Farm reform can answer Trump with new Green Revolution

Standing up to America is usually not a personal risk for a leader in India. Any suggestions of foreign pressure unites India behind who they see as leading them in that fight.